Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7539)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 19, 2021 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chang SC, Goh KK, Lu ML. Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives. World J Psychiatr 2021; 11(10): 696-710 [PMID: 34733637 DOI: 10.5498/wjp.v11.i10.696] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v11/i10/696.htm |
| Number | Citing Articles |
| 1 |
Katerina Horska, Silje Skrede, Jan Kucera, Gabriela Kuzminova, Pavel Suchy, Vincenzo Micale, Jana Ruda‐Kucerova. Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model. CNS Neuroscience & Therapeutics 2024; 30(2) doi: 10.1111/cns.14565
|
| 2 |
Giuseppe Forte, Francesca Favieri, Mariella Pazzaglia, Maria Casagrande. Mental and Body Health: The Association between Psychological Factors, Overweight, and Blood Pressure in Young Adults. Journal of Clinical Medicine 2022; 11(7): 1999 doi: 10.3390/jcm11071999
|
| 3 |
Shokouh Arjmand, Caroline Biojone, Gregers Wegener. Modulation of Leucine Sensors to Mitigate Antipsychotics-Induced Metabolic Syndrome: A New Vista. ACS Pharmacology & Translational Science 2024; 7(1): 294 doi: 10.1021/acsptsci.3c00319
|
| 4 |
Marco Carli, Francesco Weiss, Giovanna Grenno, Sergio Ponzini, Shivakumar Kolachalam, Francesca Vaglini, Cristina Viaggi, Carla Pardini, Simone Tidona, Biancamaria Longoni, Roberto Maggio, Marco Scarselli. Pharmacological Strategies for Bipolar Disorders in Acute Phases and
Chronic Management with a Special Focus on Lithium, Valproic Acid, and
Atypical Antipsychotics. Current Neuropharmacology 2023; 21(4): 935 doi: 10.2174/1570159X21666230224102318
|
| 5 |
Maximilian Gahr. Metabolische unerwünschte Arzneimittelwirkungen von
Psychopharmaka. Fortschritte der Neurologie · Psychiatrie 2024; doi: 10.1055/a-2405-5087
|
| 6 |
Wei Zhou, Jing Sun, Cong Huai, Yunxi Liu, Luan Chen, Zhenghui Yi, Qinyu Lv, Chuanfu Song, Wenli Zhu, Chuanxin Liu, Saizheng Weng, Hao Wu, Yidan Sun, Runshuai Zhang, Lianfeng Wu, Mo Li, Jinhang Zhu, Yingtian Zhang, Muyun Wei, Yujian Guo, Sijia Huang, Na Zhang, Ruoxi Shen, Ying Zhang, Huihui Du, Hailiang Huang, Lin He, Xiaofang Sun, Lu Shen, Shengying Qin. Multi-omics analysis identifies rare variation in leptin/PPAR gene sets and hypermethylation of ABCG1 contribute to antipsychotics-induced metabolic syndromes. Molecular Psychiatry 2022; 27(12): 5195 doi: 10.1038/s41380-022-01759-5
|
| 7 |
E. G. Kornetova, A. A. Goncharova, I. A. Mednova, A. N. Kornetov, T. V. Saprina, O. E. Perchatkina, A. V. Semke. Somatotype and morphological characteristics of metabolic syndrome in patients with schizophrenia and persons without mental disorders. Bulletin of Siberian Medicine 2023; 22(1): 57 doi: 10.20538/1682-0363-2023-1-57-64
|
| 8 |
Nicolette Stogios, Bailey Humber, Sri Mahavir Agarwal, Margaret Hahn. Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations. Current Psychiatry Reports 2023; 25(11): 707 doi: 10.1007/s11920-023-01458-0
|
| 9 |
A.S. Prathiksha, Pawar Mansi Shantaram, Muhammed Rashid, Pooja Gopal Poojari, Sreedharan Nair, Leelavathi D. Acharya, Girish Thunga. Determinants of and barriers to diabetes care among patients with serious mental illness: A scoping review with recommendations. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2024; 18(10): 103139 doi: 10.1016/j.dsx.2024.103139
|
| 10 |
Pelumi Samuel Akinola, Isabelle Tardif, Jacinthe Leclerc. Antipsychotic-Induced Metabolic Syndrome: A Review. Metabolic Syndrome and Related Disorders 2023; 21(6): 294 doi: 10.1089/met.2023.0003
|
| 11 |
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu-Hua Wu, Chun-Hsin Chen, Mong-Liang Lu. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction. International Journal of Molecular Sciences 2022; 23(13): 7092 doi: 10.3390/ijms23137092
|
| 12 |
Zhiyong Gao, Meihong Xiu, Jiahong Liu, Fengchun Wu, Xiang-Yang Zhang. Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone. Schizophrenia 2023; 9(1) doi: 10.1038/s41537-023-00346-z
|
| 13 |
Stephanie Sogg, Sanjeev Sockalingam, Susan Himes, Susan J. Penava, Noreen A. Reilly-Harrington. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 2025; : 791 doi: 10.1016/B978-0-443-11844-9.00072-2
|
| 14 |
Nousayhah Amdanee, Miaomiao Shao, Xiuxiu Hu, Xinyu Fang, Chao Zhou, Jiu Chen, Mohammad Ridwan Chattun, Lu Wen, Xinming Pan, Xiangrong Zhang, Yue Xu. Serum Metabolic Profile in Schizophrenia Patients With Antipsychotic-Induced Constipation and Its relationship With Gut Microbiome. Schizophrenia Bulletin 2023; 49(3): 646 doi: 10.1093/schbul/sbac202
|
| 15 |
Katja Häkkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo, Olli Kampman, Erkki Isometsä, Tuula Kieseppä, Jouko Lönnqvist, Jaana Suvisaari, Jarmo Hietala, Jari Tiihonen, Aarno Palotie, Ari V. Ahola-Olli, Mikko Niemi. Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder. Molecular Pharmaceutics 2023; 20(3): 1500 doi: 10.1021/acs.molpharmaceut.2c00715
|
| 16 |
Chao Yang, Xiaoxiao Lin, Xianteng Wang, Huanzhong Liu, Jinyu Huang, Shuai Wang. The schizophrenia and gut microbiota: A bibliometric and visual analysis. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.1022472
|
| 17 |
Jose M. Rubio, John M. Kane. The pharmacological treatment of schizophrenia: How far have we come?. Psychiatry and Clinical Neurosciences Reports 2022; 1(2) doi: 10.1002/pcn5.13
|
| 18 |
Eva-Maria Tsapakis, Konstantinos N. Fountoulakis, Stefania Kanioura, Haim Einat. Significant contribution of chronotype to emotional well-being in chronic psychiatric outpatients in Greece. Neuroscience Applied 2024; 3: 103940 doi: 10.1016/j.nsa.2024.103940
|
| 19 |
Kuan Zeng, Shuo Wang, Lin Zhang, Yanting Zhang, Jun Ma. Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patients. Annals of General Psychiatry 2023; 22(1) doi: 10.1186/s12991-023-00455-0
|
| 20 |
Zhongzi Ma, Zhongnv Ma. Relationship between stable smoking behavior and cognitive function in male schizophrenia patients. Journal of Psychiatric Research 2024; 173: 296 doi: 10.1016/j.jpsychires.2024.03.034
|
| 21 |
Marylee Verdi, Marcy Ainslie. A call to action: Leveraging dual-certified APRNs to optimize holistic patient care. Journal of the American Association of Nurse Practitioners 2024; 36(10): 535 doi: 10.1097/JXX.0000000000001064
|